Background: Pruritus is a cardinal symptom of atopic dermatitis, and an increased cutaneous sensory network is thought to contribute to pruritus. Although the immune cell-IL-31-neuron axis has been implicated in severe pruritus during atopic skin inflammation, IL-31's neuropoietic potential remains elusive. Objective: We sought to analyze the IL-31-related transcriptome in sensory neurons and to investigate whether IL-31 promotes sensory nerve fiber outgrowth. Methods: In vitro primary sensory neuron culture systems were subjected to whole-transcriptome sequencing, ingenuity pathway analysis, immunofluorescence, and nerve elongation, as well as branching assays after IL-31 stimulation. In vivo we investigated the cutaneous sensory neuronal network in wildtype, Il31-transgenic, and IL-31 pump-equipped mice. Results: Transgenic Il31 overexpression and subcutaneously delivered IL-31 induced an increase in the cutaneous nerve fiber density in lesional skin in vivo. Transcriptional profiling of IL-31-activated dorsal root ganglia neurons revealed enrichment for genes promoting nervous system development and neuronal outgrowth and negatively regulating cell death. Moreover, the growth cones of primary small-diameter dorsal root ganglia neurons showed abundant IL-31 receptor a expression. Indeed, IL-31 selectively promoted nerve fiber extension only in smalldiameter neurons. Signal transducer and activator of transcription 3 phosphorylation mediated IL-31-induced neuronal outgrowth, and pharmacologic inhibition of signal transducer and activator of transcription 3 completely abolished this effect. In contrast, transient receptor potential cation channel vanilloid subtype 1 channels were dispensable for IL-31-induced neuronal sprouting. Conclusions: The pruritus-and T H 2-associated novel cytokine IL-31 induces a distinct transcriptional program in sensory neurons, leading to nerve elongation and branching both in vitro and in vivo. This finding might help us understand the clinical observation that patients with atopic dermatitis experience increased sensitivity to minimal stimuli inducing sustained itch. (J Allergy Clin Immunol 2016;138:500-8.) Charity Dublin (to M.S.). Disclosure of potential conflict of interest: R. Garcia declares he is an employee of and received travel funding from Bristol-Myers Squibb. K. Lewis declares she is an employee and stockholder of receives travel funding from Bristol-Myers Squibb. S. R. Dillon is an employee of and stockholder in and receives travel funding from Bristol-Myers Squibb. M. Steinhoff declares that he has received grants from SFI IVP, the Debra Foundation, and the City of Dublin Skin Cancer Hospital Charity. The rest of the authors declare that they have no relevant conflicts of interest.
In patients with atopic dermatitis (AD), a chronic T H 2dominated inflammatory skin disease, pruritus is the cardinal symptom with the most significant adverse effect on patients' quality of life and high socioeconomic costs. 1, 2 Physical and psychological stress responses in patients with AD 3 and T H 2 cytokine-related skin barrier defects 4 might promote the pruritus sensation. Development of chronic pruritus relies not only on increased availability of itch mediators but also most likely takes advantage of increased density of cutaneous neuronal networks with prolonged sensory nerve fibers extending into the epidermal compartment. [5] [6] [7] Moreover, the diameter of these fibers appears to be thicker in skin of patients with AD because of an increased number of axons on single nerve fibers. 8 Phenotypic characterization of cutaneous nerve fibers reveals an increased number of substance P-positive and/or calcitonin gene-related protein-positive nerve fibers in the skin of atopic subjects. [9] [10] [11] Several reports have proposed a role for neurotrophins, cytokines, or both in ADassociated cutaneous nerve growth. 11, 12 However, the mechanism that controls sensory nerve fiber growth in patients with atopic skin inflammation and that might contribute to the typical pruritic hypersensitivity of patients with AD still remains elusive.
The novel atopy-associated cytokine IL-31 plays a crucial role in AD, asthma, allergic rhinitis, and mastocytosis. [13] [14] [15] IL-31 belongs to the IL-6 family of cytokines 16 and is mainly, but not exclusively, produced by activated T H 2 cells. 17, 18 Transcription of the Il31 gene in T H 2 and mast cells requires IL-4 signaling. 19 The IL-31 receptor subunits IL-31 receptor a (IL-31RA) and oncostatin M receptor b are coexpressed on sensory neurons, 20, 21 and recent evidence indicates that IL-31 from skin-infiltrating Abbreviations used AD: Atopic dermatitis DRG: Dorsal root ganglia ERK: Extracellular signal-regulated kinase IL-31RA: IL-31 receptor a IPA: Ingenuity pathway analysis NGF: Nerve growth factor PGP9.5: Protein gene product 9.5 PI3K: Phosphoinositide 3-kinase Prph: Peripherin gene RNA-Seq: RNA sequencing STAT3: Signal transducer and activator of transcription 3 STRT: Single cell-tagged reverse transcription Tg: Transgenic TrkA: Tropomyosin receptor kinase A TRPV1: Transient receptor potential cation channel vanilloid subtype 1 T H 2 lymphocytes can communicate with sensory neurons, thereby triggering the development of pruritus and skin lesions in mice. 17, 18, 22, 23 Skin areas devoid of T-lymphocyte infiltration are not affected by IL-31 signaling. Indeed, in patients with AD, IL-31 provides a novel link connecting Staphylococcusrelated T-cell activation and pruritus. 20 We reported recently that IL-31-induced pruritus in mice requires functional ion channels, namely transient receptor potential cation channel vanilloid subtype 1 (TRPV1) and transient receptor potential A1, on cutaneous sensory neurons and that this process is uncoupled from mast cells. 18 Moreover, pharmacologic inhibition of extracellular signal-regulated kinase (ERK1/2) signaling hampers IL-31-mediated pruritus. 18 However, neither immunosuppressants nor m-opioid receptor or a histamine H 1 antagonist alleviate pruritus elicited by exogenous IL-31. 24 In contrast, in mice with chronic atopy-like skin inflammation, itchscratch cycles are significantly reduced by administration of neutralizing anti-IL-31 or anti-IL-31RA antibodies. 22, 24 Intriguingly, a recent clinical phase I trial in patients with AD using a humanized mAb targeting IL-31RA demonstrated significant improvement of pruritus, 25 providing further evidence that IL-31 links T H 2-related inflammation to pruritus.
Although the T H 2 cell-IL-31-sensory neuron axis and its role in pruritus are now well established, the question of whether IL-31 is also involved in the increased density of sensory networks within the skin remains elusive.
METHODS

Mice and sample collection
Six to 8-week-old wild-type C57BL/6, Il31ra, and Trpv1 knockout mice were kept under specific pathogen-free conditions. Il31 transgenic (Tg) mice specifically overexpressing Il31 under the Em-Lck promoter in lymphocytes 17 and control littermates were housed for up to 9 months under specific pathogen-free conditions until characteristic lesions developed spontaneously. For further details, see the Methods section in this article's Online Repository at www.jacionline.org.
Preparation and treatment of dorsal root ganglia neurons
Adult C57BL/6 mice and Il31ra knockout mice were killed and DRGs from the lumbar, thoracic, and cervical regions were removed to prepare sensory neurons from dissociated dorsal root ganglia (DRG) neurons. For further details, see the Methods section in this article's Online Repository.
Immunofluorescence and image analysis
OCT-embedded skin samples were cut in 20-mm-thick sections to analyze cutaneous innervation. For further details, see the Methods section in this article's Online Repository.
RNA sequencing and data analysis
The single cell-tagged reverse transcription (STRT) method was used 26 with minor modifications to measure transcription initiation at the 59 end of polyA 1 transcripts starting from 10 ng of total RNA as template. For further details, see the Methods section in this article's Online Repository.
Western blotting
Proteins from IL-31-activated DRG neurons were harvested with Roti-Load buffer (Carl Roth, Karlsruhe, Germany) supplemented with 2-mercaptoethanol at the indicated time points and boiled for 10 minutes. For further details, see the Methods section in this article's Online Repository.
Quantitative real-time PCR
RNA was prepared from IL-31-and nerve growth factor (NGF)-activated DRG neurons with the RNeasy kit (Qiagen, Hilden, Germany) and reverse transcribed with SuperScript II (Invitrogen, Carlsbad, Calif), according to the manufacturer's instructions. For further details, see the Methods section in this article's Online Repository.
Statistical analysis
Results are expressed as means 6 SEMs. At least 3 independent experiments were conducted (n > _ 3). Statistical analysis was performed with GraphPad Prism 5 software (GraphPad software, La Jolla, Calif). Significance was evaluated by using the paired t test, Mann-Whitney test, Wilcoxon matched-pairs signed-rank test, and 1-way ANOVA with post hoc Tukey, Newman-Keuls, or Dunnett tests. Significance was set at a P value of less than .05.
RESULTS
Transgenic overexpression of Il31 results in increased cutaneous innervation IL-31 is associated with AD and directly activates peripheral sensory neurons to induce pruritus. 18 Patients with AD with chronic pruritus show increased cutaneous innervation. 5 To unravel an additional role for IL-31 in cutaneous innervation, we took advantage of Il31Tg mice, which have an AD-like skin phenotype with severe pruritus spontaneously affecting the nape of the neck and ears (Fig 1, A , and see Fig E1 in this article's Online Repository at www.jacionline.org). First, we characterized the nerve fiber density in lesional and nonlesional skin from Il31Tg mice 17 and healthy skin from wild-type littermates (Fig  1, B) by using immunofluorescence to visualize protein gene product 9.5 (PGP9.5) 1 nerve fibers. Our results demonstrated that Il31Tg mice show a marked and significant increase in the cutaneous nerve fiber density in lesional skin (8.5 6 2.7 PGP9.5 1 fibers, P < .01) compared with that in uninvolved or healthy skin (Il31Tg nonlesional: 0.75 6 0.4 PGP9.5 1 fibers or healthy C57BL/6 wild-type: 0.42 6 0.2 PGP9.5 1 fibers; Fig 1, B and C). Expression of the DRG neuron-specific transcript peripherin gene (Prph) is increased in the skin of Il31Tg mice (see Fig E2, G, in this article's Online Repository at J ALLERGY CLIN IMMUNOL VOLUME 138, NUMBER 2 www.jacionline.org). Moreover, Il31Tg lesional skin shows significantly increased epidermal thickening (67.2 6 31.2 mm, P < .001) compared with uninvolved skin (Fig 1, D) . To further substantiate our findings, we investigated changes in the cutaneous nerve fiber density in BALB/c mice supplemented with an iso-osmotic pump dispensing mIL-31 for 14 days subcutaneously and in naive BALB/c mice. We found that continuous delivery of exogenous mIL-31 promotes development of AD-like skin lesions, pruritus/scratching, and hair loss starting from day 6 onward (see Fig E3 , D, in this article's Online Repository at www. jacionline.org). Lesional skin from IL-31-treated BALB/c mice is hyperinnervated compared with nonlesional skin and skin from naive, healthy BALB/c mice (see Fig E3, A and B) , and the abundance of the DRG neuron-specific transcript Prph is enhanced in lesional skin from mIL-31-treated BALB/c mice (see Fig E3, E) . Moreover, IL-31 increases epidermal thickening in BALB/c mice (see Fig E3, C) .
IL-31 induces distinct genes related to neuronal growth in primary DRG neurons
To further study IL-31's neuropoietic potential and to compare its function with the well-characterized neurotrophin NGF, we analyzed their transcriptional profiles using RNA sequencing (RNA-Seq; see Fig E4 in this article's Online Repository at www. jacionline.org). First, we found that IL-31 and NGF significantly upregulate 259 and 216 genes in dissociated DRG neurons, respectively. Notably, only 31 genes were shared between these treatment conditions (Fig 2, A) . Surprisingly, very few genes were downregulated (6 by IL-31 and 12 by NGF), suggesting that both factors activate DRG neurons (Fig 2, A) . To validate the IL-31 data set, 6 randomly selected upregulated genes (Il31ra, Shroom3, Nts, Rcan1, Sema6D, and Cyth2) were analyzed in biological replicates (n 5 4-5), and 5 of 6 genes were significantly induced by IL-31 (see Fig E2) , supporting the reliability of the RNA-Seq data set.
Next, differentially expressed genes were annotated and assigned to functional biological classes. Although upregulating different gene sets, both IL-31-and NGF-related genes belong to the same functional classes, such as cell morphology/adhesion, gene expression, (protein) metabolism, neuronal, and transport(er) (Fig 2, B) . Moreover, ingenuity pathway analysis (IPA) revealed that 7 of the 10 most significantly enriched pathways are shared between IL-31-and NGF-activated neurons (eukaryotic translation initiation factor 2 signaling, oxidative phosphorylation, gluconeogenesis I, mitochrondrial dysfunction, unfolded protein response, glycolysis I, and ERK/mitogen-activated protein kinase signaling; Fig 2, C) . However, IPA also identified enrichment of signaling pathways specific for IL-31 (eg, 14-3-3 signaling, mechanistic target of rapamycin signaling, phosphoinositide 3-kinase [PI3K]/AKT signaling, and integrin-linked kinase signaling) or NGF (eg, Gi signaling, cyclic AMPmediated signaling, and cholesterol biosynthesis I; see Fig E4 in this article's Online Repository at www.jacionline.org). Interestingly, IPA indicated that differentially expressed genes associated with either IL-31 or NGF stimulation are related to a variety of functional annotations within 3 central categories: nervous system development (Fig 2, D) , cell death and survival (Fig 2, E) , and cellular movement (Fig 2, F) . In these categories IL-31-and NGF-induced gene sets not only promote overlapping biological responses but also relate to different functional annotations. However, if linked to different functional annotations, the IL-31-and NGF-activated genes can be assigned to similar biological functions promoting neuronal growth (Fig 2, D) , cell death and survival (Fig 2, E) , and cellular movement (Fig 2, F) . The activation z score indicates the direction of regulation: positive (score > 1) and negative (score < 21). EIF2, Eukaryotic translation initiation factor 2; ILK, integrin-linked kinase; MAPK, mitogen-activated protein kinase. #Number of enriched molecules.
(regeneration of peripheral nerve, neuronal outgrowth, and cell survival; see Fig E4) and cell movement (Fig 2, F) . Indeed, within the category of nervous system development, IL-31 positively regulates the quantity of neurites and the extension of neurites, whereas NGF induces genes positively regulating the quantity of neurons and growth of axons (activation z score > 1; Fig 2, D) . In contrast, activation of functions like necrosis, apoptosis, and cell death is negatively regulated in response to both IL-31 and NGF (activation z score < 21; Fig 2, E) .
IL-31 promotes neuronal growth in small-diameter neurons
To analyze the distribution pattern and coexpression of IL-31RA and tropomyosin receptor kinase A (TrkA; the specific NGF receptor) in neuron subsets, we performed immunofluorescence staining on primary DRG neurons isolated from wild-type mice. We found that IL-31RA is expressed only on smalldiameter neurons (diameter, <20 mm), whereas TrkA is found on small-and large-diameter (diameter, >20 mm) neurons ( Fig 3, A and B, upper panel). Only 21% 6 9% of all IL-31RA 1 DRG neurons also stain positive for TrkA (Fig 3, B , lower panel). Moreover, in IL-31-activated DRG neurons, IL-31RA is located in the growth cones and cell bodies (Fig 3, C) . To further investigate the role of IL-31 in neuronal outgrowth, whole DRG explants from wild-type mice (n 5 6) were stimulated with IL-31 or control (n 5 19 DRGs per condition), and the length of the 10 longest neurites per DRG was measured. Interestingly, stimulation of whole DRG explants with IL-31 for 3 days leads to (1) increased neuronal growth and (2) neurite elongation (Fig 3, D) . Quantitation of the length of the 10 longest neurites per DRG explant revealed that IL-31 significantly promotes nerve fiber elongation (1993 6 33.6 mm, P < .0001) compared with control values (1458 6 28.6 mm; Fig 3, D) . To further validate the finding that only small-diameter neurons are responsive to IL-31, we used cultured dissociated DRG neurons (n 5 43-58 neurons per condition in 5 independent experiments) to measure the diameter of each neuron and to treat these neurons with IL-31, NGF, or vehicle control for 24 hours. In dissociated DRG neurons with a small diameter (<20 mm), we found that both IL-31 (318.1 6 17.9 mm, P < .001) and NGF (325 6 27.8 mm, P < .01) induce nerve fiber elongation compared with control neurons (220.6 6 14.2 mm; Fig 4, A and B) . Interestingly, in contrast to NGF, IL-31 also promoted increased branching of the longest neurites extending from small-diameter neurons prepared from wild-type mice (<20 mm, P 5 .01; Fig 4, C) . In large-diameter neurons (>20 mm) only NGF, but not IL-31, affected nerve fiber elongation (Fig 4, D) . To confirm that IL-31 biology is mediated by its specific receptor IL-31RA, we prepared dissociated DRG neurons derived from Il31ra-deficient mice. In contrast to wild-type mice, IL-31 did not augment neuronal elongation and branching of small-diameter neurons of 
Signal transducer and activator of transcription 3 phosphorylation links IL-31 and nerve fiber elongation
To identify the signaling pathway involved in IL-31-related neuronal growth in DRG neurons, we first studied the IL-31mediated phosphorylation of ERK1/2 and signal transducer and activator of transcription 3 (STAT3) using Western blotting. We found that IL-31 triggers both ERK1/2 (P < .05) and STAT3 (P < .05) phosphorylation in dissociated DRG neurons (n 5 6 independent experiments; Fig 5, A-C). Because STAT3 is a common mediator of neuronal growth response, 27 
IL-31-induced nerve fiber elongation is independent of TRPV1
Previously, we demonstrated that IL-31-induced pruritus requires active TRPV1 channels. 18 Thus we further aimed to determine the contribution of TRPV1 to IL-31-induced neurite outgrowth. Using Trpv1-deficient mice, we showed that IL-31 promotes neurite outgrowth independently of TRPV1 (n 5 16-20 DRGs per condition in 3 independent experiments; Fig 5, F) . 
DISCUSSION
In patients with AD, agonizing itch sensation involves an increased density of cutaneous sensory nerve fibers. 5 Current concepts implicate an imbalance of neurotrophins and repulsive factors as participating in pruritus-associated pathology. 6 Because AD represents a chronic inflammatory disease, a role for T H 2 cytokines in promoting the elongation of sensory nerves during atopic skin inflammation has also been proposed. 12 Here, for the first time in a murine model, we report that the T H 2-related and atopy-associated cytokine IL-31 directly promotes nerve fiber elongation in vitro and in vivo (Figs 1, 3 , and 4). Moreover, we demonstrate that IL-31 increases neurite branching in activated DRG neurons (Fig 4, C) . Intriguingly, AD-related factors, such as IL-4 and staphylococcal enterotoxin B, augment IL-31 production in human subjects, 20, 28 suggesting that endogenous and/or environmental triggers might engage the IL-31 pathway to promote cutaneous innervation in atopic subjects. Indeed, transcriptional profiling of IL-31-activated DRG neurons from mice further supports a neuropoietic function of IL-31. Pathway analysis revealed enrichment for pathways related to neurogenesis in general and to neurite branching and elongation of neurites in particular (Fig 2, D , and see the Methods section in this article's Online Repository). Interestingly, IPA indicated an IL-31induced innervation of the skin response (see Fig E4) . Moreover, our findings are also supported by initial correlative findings by Murota et al. 29 IL-31 has been assigned to the IL-6 family of cytokines, 16 which emerged as a cytokine family with dual functions: inflammation and neuropoiesis. 30 The IL-6 family members leukemia inhibitory factor, ciliary neurotrophic factor, and oncostatin M regulate nervous system development, neuronal survival, or repair 30-34 through a selective receptor heterodimer specific for each IL-6 family member. However, unlike all other IL-6 family-related receptor heterodimers, the IL-31 receptor complex uses a unique gp130-like receptor chain IL-31RA. 16 Our recent studies revealed that IL-31RA is expressed exclusively on a subset of small-diameter neurons (<20 mm; Fig 3, A) of TRPV1 1 peptidergic murine DRG neurons, which evokes profound scratching in mice through an ERK1/2-dependent mechanism. 18 The clinical relevance of these findings is supported by the positive results of a recent clinical study using a neutralizing anti-IL-31RA mAb to control pruritus in patients with AD. 25 Here we demonstrate that IL-31RA is targeted to the growth cones of primary sensory neurons (Fig 3, C) , further suggesting an essential role for IL-31 in neuron-growth cone guidance, as demonstrated previously for other neurotrophins. 35, 36 Previously, the dysregulation of NGF and semaphorin 3A was proposed to explain how increased cutaneous sensory nerve density is regulated in patients with AD. 6 In this model keratinocyte-derived NGF is one of the mediators determining the innervation density in skin of patients with AD, which is characterized by decreased levels of the repulsive axon guidance factor semaphorin 3A. 37, 38 Nonetheless, current evidence suggests that additional T H 2 inflammation-related mechanisms are triggering skin innervation and scratching behavior in mice with chronic AD. 12 Although intradermal injection of mIL-31 induces intense immediate pruritus in mice, 18 Hawro et al 23 reported that skin prick testing with human IL-31 only induced delayed pruritus (9/20 subjects) 2 hours after injection. Hence further research will be necessary to investigate how IL-31 directly or indirectly communicates with neurons to cause pruritus in human subjects.
In the present study we extend our understanding of the neuronal function of IL-31 promoting the elongation of IL-31RA 1 neurons (Figs 3, D, and 4). Immunofluorescence analysis of IL-31RA 1 neurons further revealed that only the minority of IL-31-responsive neurons coexpresses TrkA (Fig 3,  A and B) , proposing that IL-31 elongates a unique subset of itch-conducting sensory nerve fibers that are unresponsive to NGF. To further characterize the differences/similarities between IL-31-and NGF-induced nerve fiber out growth, we compared the transcriptional profiles of murine DRG neurons cultured with IL-31 or NGF by means of whole-transcriptome sequencing. Intriguingly, although IL-31 and NGF enrich genes that relate to similar biological processes, the transcriptional profile is quite different (Fig 2) , suggesting that both agonists might activate different neurons. IL-31 stimulation leads to enrichment of signaling pathways linked to nervous system development and survival: PI3K/AKT, mitogen-activated protein kinase, mammalian target of rapamycin, and 14-3-3 signaling. [39] [40] [41] [42] Interestingly, pathways enriched and positively regulated in response to IL-31, like PI3K/AKT and integrin-linked kinase signaling, trigger peripheral axon regeneration, 43 axonal elongation, 41 and neuronal polarity. 44 STAT3 was identified as (1) an important positive regulator of peripheral nerve regeneration and neuronal outgrowth 27, 45 and (2) a protective factor rescuing from axonal degeneration, 46 thus strongly suggesting a role for STAT3 in IL-31-related nerve fiber growth responses. These findings are supported by IL-31-induced STAT3 phosphorylation in murine neurons ( Fig 5, A and B ) and the fact that pharmacologic inhibition of the STAT3 pathway completely abolishes IL-31-mediated neuron outgrowth ( Fig 5, D and E) . Interestingly, it has been reported recently that NGF requires basal activity of the IL-6 family receptor-related gp130 to induce STAT3 phosphorylation and to promote neuronal outgrowth in DRG neurons, 45 suggesting that both IL-31 and NGF promote nerve fiber elongation through STAT3 phosphorylation but target different neuron subsets. Recently, we could demonstrate that IL-31-induced itch sensation in mice critically depends on ERK1/2 and functional TRPV1 channels. 18 Although previous studies associated Trpv1 with neuritogenesis, 47 our findings in TRPV1-deficient mice show that IL-31-induced sensory neuron elongation and branching were independent of TRPV1 engagement (Fig 5, F) . Hence these results suggest that one stimulus, IL-31, uses different signaling traits to evoke distinct downstream phenotypes.
In patients with AD, intractable pruritus causes severe clinical challenges and relies, on the activation of the IL-31 axis, among other factors. Based on previous findings and the results of the present study, we suggest the following model for the role of the IL-31 axis in the skin. First, during atopic skin inflammation, immune cells, such as T H 2 cells, mast cells, or both, communicate with cutaneous IL-31RA 1 sensory neurons through IL-31 secretion and induce itch sensations. Second, subsequently, chronic IL-31-driven ''atopic'' stimulation of cutaneous sensory neurons can result in cutaneous sensory nerve fiber elongation and branching, leading to increased sensory nerve fiber density in patients with AD. Third, given the enhanced sensory network within the skin, it is conceivable that itch thresholds are decreasing and that minimal doses of pruritogens can result in triggering symptoms in atopic subjects.
Taken together, because of its role in inflammation, itch, and nerve elongation, therapeutic targeting of the IL-31/IL-31RA pathway might be an attractive approach to break vicious itch-scratch-eczema cycles and to improve the patient's quality of life.
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Key messages
d The pruritus-and T H 2-associated novel cytokine IL-31 induces a distinct transcriptional program in sensory neurons.
d IL-31 induces the outgrowth of sensory neurons in a STAT3-dependent manner.
d Translational effect: IL-31-associated nerve elongation might be involved in skin hypersensitivity of patients with AD to pruritogenic trigger factors.
METHODS
Mice and sample collection
Six to 8-week-old wild-type C57BL/6 and Trpv1 knockout mice were kept under specific pathogen-free conditions. Il31Tg mice specifically overexpressing Il31 under the Em-Lck promoter in lymphocytes E1 and control littermates were housed for up to 9 months under specific pathogen-free conditions until characteristic lesions developed spontaneously. Subsequently, punch biopsy specimens from lesional and nonlesional skin were collected. An IL-31 pump study in BALB/c mice was performed. Briefly, BALB/c mice received 20 mg/d recombinant mouse IL-31 (mIL-31; ZymoGenetics, Seattle, Wash) for 14 days delivered subcutaneously through a miniosmotic pump (Alzet Osmotic Pump; Durect, Cupertino, Calif). The skin phenotype was monitored daily and scored based on pruritus, hair loss, and lesion development: 0, no scratching or hair loss; 1, minimal scratching and thinning of the coat in small areas; 2, scratching with minor hair loss; 3, scratching with moderate hair loss and lesion development; and 4, excessive scratching with severe hair loss and lesion development. Skin biopsy specimens were taken from the area in which the pump was dispensing mIL-31. All animal procedures were approved by the ZymoGenetics Institutional Animal and Care and Use Committee or by the local government committee, the ''Landesamt fuer Natur, Umwelt und Verbraucherschutz Nordrhein-Westfalen.''
Preparation and treatment of DRG neurons
To prepare sensory neurons from dissociated DRG neurons, adult C57BL/6 mice were killed, and DRGs from the lumbar, thoracic, and cervical regions were removed. DRGs were trimmed of connective tissue and nerve roots and then treated with 3 mg/mL collagenase (Sigma-Aldrich, St Louis, Mo) and 0.25 mg/mL trypsin (PAA Laboratories/GE Healthcare) for 30 minutes. DRGs were triturated for dissociation to prepare a single-cell suspension. To generate whole DRG explants, DRGs derived from C57BL/6 mice or Trpv1 knockout mice were isolated, as described above, except that connective tissue was digested with 0.3% collagenase for 30 minutes only. Both dissociated DRG neurons and whole DRG explants were plated onto cell-culture dishes (for RNA and protein extraction) or glass slides (for immunofluorescence) coated with poly-L-lysine (0.1-1 mg/mL, Sigma-Aldrich) and laminin (5 mg/mL, Sigma-Aldrich). Cells were cultured in minimal essential medium supplemented with 10% horse serum, 1% penicillin/streptomycin, 1% vitamins, 1% N2-supplement, and 2% B27-supplement for recovery. Cultured DRGs were stimulated with 100 ng/mL mIL-31 (ZymoGenetics) or 10 ng/mL NGF (Sigma-Aldrich) for the indicated time points. In selected experiments 2 mmol/L (dissociated DRG neurons) or 20 mmol/L (whole DRG explants) of the STAT3 inhibitor V/Stattic (Calbiochem, San Diego, Calif) was applied 1 hour before IL-31 stimulation.
Immunofluorescence and image analysis
OCT-embedded skin samples were cut in 20-mm-thick sections to analyze cutaneous innervation. Sections were either fixed with Zambonis fixative (MORPHISTO, Frankfurt, Germany) or 4% paraformaldehyde, blocked with 2% BSA and 10% donkey serum in 0.5% Triton X-100 containing PBS, and stained with 2.5 mg/mL rabbit anti-PGP9.5 pAb (EMD Millipore, Billerica, Mass), anti-rabbit Alexa Fluor 555 (Invitrogen), and 49-6-diamidino-2-phenylindole dihydrochloride (DAPI; Molecular Probes, Eugene, Ore). Confocal image stacks at 320 magnification were taken with the Zeiss LSM 510 (Zeiss, Oberkochen, Germany) supplemented with Zen software and ''flattened'' into a single image before nerve fiber quantification. Cutaneous PGP9.5 1 fibers were quantified in preprocessed images by 3 independent blind researchers. DRG neurons were first fixed with 1% paraformaldehyde/7.5% sucrose for 30 minutes and then for another 30 minutes in 2% paraformaldehyde/15% sucrose to quantify axonal growth and to identify the cellular IL-31RA localization. DRG neurons were stained with 10 mg/mL anti-bIII-tubulin (Sigma-Aldrich), 14.8 mg/mL rat anti-mouse IL-31RA mAb (ZymoGenetics), and anti-rabbit Alexa Fluor 488 or anti-rat Alexa Fluor 594 (both Invitrogen), according to standard methods. Images were taken with a Zeiss Cell Observer, Axiovision and Mosaix software, or a Zeiss LSM 510 supplemented with Zen software (all from Zeiss). The length of each neurite was measured as the distance from the end of the neurite straight back to the DRG body radially. E2 Cryopreserved, OCT-embedded whole DRGs plucked from the spinal columns of C57BL/6 mice were cut in 10-mm-thick sections. Sections were stained with 14.8 mg/mL rat anti-mouse IL-31RA (ZymoGenetics), 2.9 mg/mL rabbit anti-mouse TrkA (Abcam, Cambridge, United Kingdom), anti-rat Alexa Fluor 555, and anti-rabbit Alexa Fluor 488 (both from Invitrogen), according to standard methods, to visualize the distribution of IL-31-and NGFresponsive neurons. Photographs were taken with the Zeiss Cell Observer. For all immunofluorescence staining, at least 3 independent experiments were performed.
RNA-Seq and data analysis
The STRT method was used, E3 with minor modifications, to measure transcription initiation at the 59 end of polyA 1 transcripts starting from 10 ng of total RNA as template. RNA samples from DRG neurons (from n 5 3 independent experiments) were arranged in the plate, and each one was sequenced with an individual barcode. The capture buffer contained 10 mmol/L Tris-HCl (pH 8.0), 0.1% Triton X-100, 800 nmol/L T30-VN-oligo, 2 mmol/L dNTP mixture, and 2 mmol/L template switching oligos barcoding the sample. The cDNAs were pooled into one tube by using 10% PEG-6000 and 0.9 mol/L NaCl and amplified by using 14 cycles of PCR and 10 additional cycles to introduce the complete sets of adapters for Illumina sequencing (Illumina, San Diego, Calif). The libraries were size selected (200-400 bp) by using sequential AMPure XP bead selection protocol and 0.73 and 0.223 ratios.
The sequences of the STRT libraries were preprocessed to (1) demultiplex by sample barcodes; (2) exclude redundant reads to reduce PCR bias by unique molecular identifiers E4 ; (3) align the reads to the mouse reference genome mm9, the mouse ribosomal DNA repeating unit (GenBank:BK000964), and spike-in sequences by using TopHat E5 ; (4) quantify the expression levels in 50-bp strand-specific windows sliding in 25-bp steps; and (5) perform the basal quality check of the library and the sequencing. Then the differential expression was tested by using SAMstrt. E6 For analysis, only sequences that aligned to coding DNA sequence, coding upstream, and coding 59 untranslated region were selected, and duplicates were removed. Annotation was done manually with information in GenBank, PubMed, and pfam alignments to assign individual genes to functional classes to generate a detailed (level 1: 44 classes for IL-31-cultured DRG neurons and 48 classes for NGF cultured DRG neurons) annotation or an overview (level 2: 10 classes for both culture conditions) with broader functional classes. Genes that were not characterized and did not have any informative pfam motifs were annotated as ''Unknown.'' Summary (level 2) data sets were then plotted in a bar chart format to compare functional classes after induction of gene expression by IL-31 or NGF.
Biological functions associated with differentially expressed genes were identified by using IPA. We performed a global canonical pathway enrichment analysis and functional enrichment analysis of diseases and functions. Three functional categories of interest were considered: cell death, cellular movement, and nervous system development. Differentially expressed genes associated with NGF and IL-31 were analyzed independently to identify biological functions and were ranked were based on the summed -log(P value) across both NGF and IL-31. Death and Survival  necrosis  0,000117  -1,455  ADRM1,ALDOA,APRT,ATF3,ATF4,ATP1A1,AU  RKA,BDNF,CCT5,CD274,CLU,CST3,CTBP1,D  DIT3,DTYMK,FKBP4,GNAO1,GNB2,GSTM5,H  SPA4,ILK,ITGA7,LDHA,LRPAP1,MAD2L1, 0,00239  -2,712  AKAP12,BCR,BDNF,BHLHE40,CAV1,DAXX,D  NAJC15,FKBP8,FTH1,GAL,HES1,HNRNPK,ID  1,INHBA,MYC,NCL,PLAUR,PLK2,PRKAR1A,P  TGS2,RABGGTB,RTN1,S1PR3,TIMP1,TNFAI  P8,TRIM10,TUBA1A 27 0,000187  AGA,AKAP12,BCR,BDNF,CANX,CAV1,Ccl2,D  CLK1,FKBP8,GAL,GM2A,HES1,ID1,ID2,LMN  A,MYC,NPY1R,PLAUR,SCYL1,SLC17A6,TUB  A1A,UPP1,VIM   23 Cell 
Western blotting
